Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Regeneron Pharmaceuticals Revenue 2006-2019 | REGN

Regeneron Pharmaceuticals annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Regeneron Pharmaceuticals revenue for the quarter ending June 30, 2019 was $1.934B, a 20.25% increase year-over-year.
  • Regeneron Pharmaceuticals revenue for the twelve months ending June 30, 2019 was $7.237B, a 16.67% increase year-over-year.
  • Regeneron Pharmaceuticals annual revenue for 2018 was $6.711B, a 14.28% increase from 2017.
  • Regeneron Pharmaceuticals annual revenue for 2017 was $5.872B, a 20.82% increase from 2016.
  • Regeneron Pharmaceuticals annual revenue for 2016 was $4.86B, a 18.44% increase from 2015.
Regeneron Pharmaceuticals Annual Revenue
(Millions of US $)
2018 $6,711
2017 $5,872
2016 $4,860
2015 $4,104
2014 $2,820
2013 $2,105
2012 $1,378
2011 $446
2010 $459
2009 $379
2008 $238
2007 $125
2006 $63
2005 $66
Regeneron Pharmaceuticals Quarterly Revenue
(Millions of US $)
Q2 2019 $1,934
Q1 2019 $1,712
Q4 2018 $1,928
Q3 2018 $1,663
Q2 2018 $1,608
Q1 2018 $1,512
Q4 2017 $1,582
Q3 2017 $1,501
Q2 2017 $1,470
Q1 2017 $1,319
Q4 2016 $1,227
Q3 2016 $1,220
Q2 2016 $1,213
Q1 2016 $1,201
Q4 2015 $1,098
Q3 2015 $1,137
Q2 2015 $999
Q1 2015 $870
Q4 2014 $802
Q3 2014 $726
Q2 2014 $666
Q1 2014 $626
Q4 2013 $610
Q3 2013 $597
Q2 2013 $458
Q1 2013 $440
Q4 2012 $415
Q3 2012 $428
Q2 2012 $304
Q1 2012 $232
Q4 2011 $123
Q3 2011 $103
Q2 2011 $108
Q1 2011 $112
Q4 2010 $134
Q3 2010 $106
Q2 2010 $116
Q1 2010 $104
Q4 2009 $97
Q3 2009 $117
Q2 2009 $90
Q1 2009 $75
Q4 2008 $56
Q3 2008 $66
Q2 2008 $61
Q1 2008 $56
Q4 2007 $65
Q3 2007 $22
Q2 2007 $22
Q1 2007 $16
Q4 2006 $10
Q3 2006 $16
Q2 2006 $19
Q1 2006 $18
Q4 2005 $17
Q3 2005 $16
Q2 2005 $16
Q1 2005 $16
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $32.193B $6.711B
Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma and has preclinical programs in other diseases and disorders.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.526B 13.61
Gilead Sciences (GILD) United States $79.622B 9.78
Celgene (CELG) United States $66.133B 10.23
Vertex Pharmaceuticals (VRTX) United States $46.554B 50.31
Biogen (BIIB) United States $41.986B 7.46
Illumina (ILMN) United States $41.861B 49.18
CSL (CSLLY) Australia $34.685B 0.00
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.450B 12.89
Incyte (INCY) United States $17.337B 51.02
Exact Sciences (EXAS) United States $15.308B 0.00
SINO PHARMACEUT (SBMFF) China $15.039B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.873B 0.00
Genmab (GNMSF) Denmark $12.608B 64.09
Seattle Genetics (SGEN) United States $12.406B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.477B 50.81
Guardant Health (GH) United States $9.197B 0.00
Sarepta Therapeutics (SRPT) United States $9.067B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.715B 0.00
Galapagos (GLPG) Belgium $8.688B 0.00
QIAGEN (QGEN) Netherlands $7.764B 25.50
Bio-Techne Corp (TECH) United States $7.304B 50.48
BeiGene (BGNE) Cayman Islands $6.704B 0.00
Bluebird Bio (BLUE) United States $6.466B 0.00
Exelixis (EXEL) United States $6.040B 15.70
Amarin (AMRN) Ireland $5.158B 0.00
Horizon Pharma Public (HZNP) Ireland $5.004B 12.72
Ascendis Pharma (ASND) Denmark $4.838B 0.00
Repligen (RGEN) United States $4.555B 88.40
ARGENX SE-ADR (ARGX) Netherlands $4.335B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.193B 0.00
Moderna (MRNA) United States $4.183B 0.00
Blueprint Medicines (BPMC) United States $4.014B 0.00
Spark Therapeutics (ONCE) United States $3.853B 0.00
China Biologic Products (CBPO) China $3.821B 23.85
MorphoSys AG (MOR) Germany $3.777B 0.00
Mirati Therapeutics (MRTX) United States $3.541B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.281B 0.00
Alkermes (ALKS) Ireland $3.276B 0.00
Immunomedics (IMMU) United States $2.759B 0.00
Genomic Health (GHDX) United States $2.752B 51.61
Arena Pharmaceuticals (ARNA) United States $2.635B 5.66
NeoGenomics (NEO) United States $2.549B 136.33
Amicus Therapeutics (FOLD) United States $2.544B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.520B 0.00
Medicines (MDCO) United States $2.501B 0.00
MyoKardia (MYOK) United States $2.460B 0.00
Acceleron Pharma (XLRN) United States $2.372B 0.00
Halozyme Therapeutics (HALO) United States $2.319B 0.00
Emergent Biosolutions (EBS) United States $2.223B 33.40
Reata Pharmaceuticals (RETA) United States $2.197B 0.00
UniQure (QURE) Netherlands $2.120B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.113B 0.00
Cambrex (CBM) United States $2.012B 25.43
Zai Lab (ZLAB) China $1.944B 0.00
Akcea Therapeutics (AKCA) United States $1.914B 0.00
Ligand Pharmaceuticals (LGND) United States $1.745B 22.06
Myriad Genetics (MYGN) United States $1.714B 17.98
Denali Therapeutics (DNLI) United States $1.689B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.585B 0.00
Insmed (INSM) United States $1.382B 0.00
AnaptysBio (ANAB) United States $1.352B 0.00
RA PHARMCTL INC (RARX) United States $1.350B 0.00
REGENXBIO (RGNX) United States $1.308B 0.00
Coherus BioSciences (CHRS) United States $1.291B 0.00
Sangamo Therapeutics (SGMO) United States $1.278B 0.00
Editas Medicine (EDIT) United States $1.256B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.212B 0.00
Epizyme (EPZM) United States $1.168B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.165B 0.00
Fate Therapeutics (FATE) United States $1.150B 0.00
Athenex (ATNX) United States $1.145B 0.00
Innoviva (INVA) United States $1.136B 3.28
Alector (ALEC) United States $1.023B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.997B 0.00
Zymeworks (ZYME) Canada $0.979B 0.00
Twist Bioscience (TWST) United States $0.938B 0.00
Cara Therapeutics (CARA) United States $0.900B 0.00
Principia Biopharma (PRNB) United States $0.868B 452.88
BAVARIAN NORDIC (BVNRY) Denmark $0.853B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.821B 0.00
Intellia Therapeutics (NTLA) United States $0.820B 0.00
ANI Pharmaceuticals (ANIP) United States $0.812B 13.55
Adverum Biotechnologies (ADVM) United States $0.804B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.794B 28.67
Arvinas (ARVN) United States $0.783B 0.00
Codexis (CDXS) United States $0.777B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.774B 0.00
Anika Therapeutics (ANIK) United States $0.760B 26.90
Cytokineticsorporated (CYTK) United States $0.733B 0.00
Retrophin (RTRX) United States $0.730B 0.00
Pharming Group (PHGUF) Netherlands $0.730B 0.00
WAVE Life Sciences (WVE) Singapore $0.697B 0.00
Vericel (VCEL) United States $0.688B 0.00
Zealand Pharma (ZLDPF) Denmark $0.672B 0.00
Zealand Pharma (ZEAL) Denmark $0.670B 7.77
Achillion Pharmaceuticals (ACHN) United States $0.659B 0.00
Stemline Therapeutics (STML) United States $0.634B 0.00
Heska (HSKA) United States $0.561B 72.73
MiMedx (MDXG) United States $0.555B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.535B 0.00
DBV Technologies S.A (DBVT) France $0.529B 0.00
Intra-Cellular Therapies (ITCI) United States $0.498B 0.00
Cellectis S.A (CLLS) France $0.489B 0.00
Revance Therapeutics (RVNC) United States $0.481B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Mesoblast (MESO) Australia $0.452B 0.00
Precision BioSciences (DTIL) United States $0.445B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.438B 0.00
UROGEN PHARMA (URGN) United States $0.429B 0.00
Syros Pharmaceuticals (SYRS) United States $0.418B 0.00
CytomX Therapeutics (CTMX) United States $0.412B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.402B 0.00
BioDelivery Sciences (BDSI) United States $0.385B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.385B 0.00
Agenus (AGEN) United States $0.380B 0.00
PHARMA MAR SA (PHMMF) Spain $0.374B 0.00
Merus (MRUS) Netherlands $0.369B 0.00
Puma Biotechnology (PBYI) United States $0.367B 0.00
Avid Bioservices (CDMO) United States $0.360B 0.00
AC Immune SA (ACIU) Switzerland $0.347B 25.70
Arcus Biosciences (RCUS) United States $0.326B 0.00
Gritstone Oncology (GRTS) United States $0.323B 0.00
Biofrontera AG (BFRA) Germany $0.323B 0.00
Bellus Health (BLUSF) Canada $0.314B 0.00
Starpharma Holdings (SPHRY) Australia $0.310B 0.00
Kadmon Holdings (KDMN) United States $0.310B 0.00
Scholar Rock Holding (SRRK) United States $0.309B 0.00
Theratechnologies (THERF) Canada $0.308B 0.00
Prothena (PRTA) Ireland $0.303B 0.00
PDL BioPharma (PDLI) United States $0.291B 7.50
Clovis Oncology (CLVS) United States $0.284B 0.00
Albireo Pharma (ALBO) United States $0.282B 0.00
Kindred Biosciences (KIN) United States $0.272B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.271B 0.00
Sorrento Therapeutics (SRNE) United States $0.271B 0.00
Protagonist Therapeutics (PTGX) United States $0.263B 0.00
Geron (GERN) United States $0.262B 0.00
Dynavax Technologies (DVAX) United States $0.255B 0.00
Senesco Technologies (ELOX) United States $0.247B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.242B 0.00
Cellular Biomedicine (CBMG) United States $0.238B 0.00
ADMA Biologics Inc (ADMA) United States $0.231B 0.00
ChromaDex (CDXC) United States $0.231B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.225B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.225B 0.00
Inovio Pharmaceuticals (INO) United States $0.217B 0.00
Kamada (KMDA) Israel $0.212B 8.09
Five Prime Therapeutics (FPRX) United States $0.211B 0.00
PHASEBIO PHARMA (PHAS) United States $0.204B 0.00
Seres Therapeutics (MCRB) United States $0.199B 0.00
MannKind (MNKD) United States $0.197B 0.00
Sutro Biopharma (STRO) United States $0.196B 0.00
Athersys (ATHX) United States $0.188B 0.00
Compugen (CGEN) Israel $0.182B 0.00
Spero Therapeutics (SPRO) United States $0.179B 0.00
Cue Biopharma (CUE) United States $0.171B 0.00
Affimed (AFMD) Germany $0.168B 0.00
POXEL SA FRANCE (PXXLF) $0.167B 0.00
Dyadic (DYAI) United States $0.167B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Novavax (NVAX) United States $0.158B 0.00
Emmaus Life Sciences (EMMA) United States $0.157B 0.00
Cerecor (CERC) United States $0.154B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.153B 0.00
Arsanis (XFOR) United States $0.152B 0.00
Nicox SA (NICXF) France $0.150B 0.00
OSMOTICA PHARM (OSMT) United States $0.149B 0.00
Enzo Biochem (ENZ) United States $0.147B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.147B 0.00
XOMA (XOMA) United States $0.144B 0.00
Synlogic (SYBX) United States $0.143B 0.00
Strongbridge Biopharma (SBBP) United States $0.140B 5.76
Lexicon Pharmaceuticals (LXRX) United States $0.140B 0.00
Adocia (ADOCY) France $0.140B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.136B 0.00
Mersana Therapeutics (MRSN) United States $0.132B 0.00
Prometic Life Sciences (PFSCF) Canada $0.130B 0.00
Acorda Therapeutics (ACOR) United States $0.126B 0.00
Alcobra (ARCT) United States $0.126B 0.00
Windtree Therapeutics (WINT) United States $0.126B 0.00
NantKwest (NK) United States $0.122B 0.00
Northwest Biotherapeutics (NWBO) United States $0.120B 0.00
Liquidia Technologies (LQDA) United States $0.117B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.114B 0.00
Celyad SA (CYAD) Belgium $0.113B 0.00
SESEN BIO, INC (SESN) United States $0.112B 0.00
Aptinyx (APTX) United States $0.110B 0.00
Aduro Biotech (ADRO) United States $0.108B 0.00
Abeona Therapeutics (ABEO) United States $0.107B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.107B 0.00
Fortress Biotech (FBIO) United States $0.106B 0.00
TOCAGEN INC (TOCA) United States $0.104B 0.00
Checkpoint Therapeutics (CKPT) United States $0.103B 0.00
Verastem (VSTM) United States $0.096B 0.00
OvaScience (MLND) United States $0.091B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.088B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.087B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.086B 0.00
Catalyst Biosciences (CBIO) United States $0.085B 0.00
Trevena (TRVN) United States $0.083B 0.00
Arbutus Biopharma (ABUS) Canada $0.081B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
Menlo Therapeutics (MNLO) United States $0.078B 0.00
Selecta Biosciences (SELB) United States $0.074B 0.00
Vaccinex (VCNX) United States $0.073B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
ARAVIVE, INC (ARAV) United States $0.069B 0.00
VTv Therapeutics (VTVT) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.066B 0.00
Curis (CRIS) United States $0.065B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.064B 0.00
Antibe Therapeutics (ATBPF) Canada $0.062B 0.00
Idera Pharmaceuticals (IDRA) United States $0.061B 0.00
VBI Vaccines (VBIV) United States $0.060B 0.00
Oncobiologics (OTLK) United States $0.058B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
AIT Therapeutics (XAIR) United States $0.056B 0.00
Applied Genetic Technologies (AGTC) United States $0.055B 30.00
Prima BioMed (IMMP) Australia $0.054B 0.00
Pluristem Therapeutics (PSTI) Israel $0.054B 0.00
China Health Industries Holdings (CHHE) China $0.054B 20.47
Unum Therapeutics (UMRX) United States $0.054B 0.00
Invo BioScience (IVOB) United States $0.051B 0.00
Ophthotech (ISEE) United States $0.046B 0.00
Clearside Biomedical (CLSD) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Evogene (EVGN) Israel $0.039B 0.00
VIVUS (VVUS) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.036B 0.00
Celsion (CLSN) United States $0.036B 0.00
Alimera Sciences (ALIM) United States $0.036B 0.00
Apricus Biosciences (SEEL) United States $0.036B 0.00
AEterna Zentaris (AEZS) United States $0.035B 0.00
Aptevo Therapeutics (APVO) United States $0.033B 0.00
Proteostasis Therapeutics (PTI) United States $0.032B 0.00
Celldex Therapeutics (CLDX) United States $0.032B 0.00
BIOCARDIA INC (BCDA) United States $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Entera Bio (ENTX) Israel $0.030B 0.20
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Signal Genetics (MGEN) United States $0.026B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
Soligenix (SNGX) United States $0.021B 0.00
VistaGen Therapeutics (VTGN) United States $0.021B 0.00
Bionano Genomics (BNGO) United States $0.018B 0.00
Vical (VICL) United States $0.018B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 6.00
TRACON Pharmaceuticals (TCON) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
CollPlant Holdings (CLGN) Israel $0.013B 0.00
Novelion Therapeutics (NVLN) Canada $0.013B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
TrovaGene (TROV) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.007B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Stellar Biotechnologies (EDSA) Canada $0.004B 0.00
Neuralstem (CUR) United States $0.002B 0.00